Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 5,960.00
+20.00 (0.34%)
At close: Jan 9, 2026
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 165.2 billion as of January 9, 2026. Its market cap has decreased by -4.64% in one year.
Market Cap
165.20B
Enterprise Value
288.87B
Revenue
493.33B
Ranking
n/a
PE Ratio
21.77
Stock Price
5,960.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 165.20B, an increase of 128.41%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 165.20B | -4.64% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |